Mechanistically, preclinical studies demonstrated that Fn promotes CRC cell proliferation in vitro and patient-derived CRC xenograft models by modulating the Wnt/β-catenin signaling pathway [81, 82]. The gene discussed is FN1; the disease is colorectal carcinoma.